Reoperation for recurrent high-grade glioma: a current perspective of the literature.
暂无分享,去创建一个
[1] Tomas Garzon-Muvdi,et al. Histopathological correlates with survival in reoperated glioblastomas , 2013, Journal of Neuro-Oncology.
[2] G. Gallia,et al. Multiple resections for patients with glioblastoma: prolonging survival. , 2013, Journal of neurosurgery.
[3] J. Brøgger,et al. γ knife surgery versus reoperation for recurrent glioblastoma multiforme. , 2012, World neurosurgery.
[4] Mitchel S Berger,et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. , 2012, Journal of neurosurgery.
[5] Susan M. Chang,et al. Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment , 2012, Neurosurgery.
[6] Mitchel S Berger,et al. An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.
[7] W. Franklin,et al. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. , 2010, International journal of radiation oncology, biology, physics.
[8] D. Scheie,et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme , 2010, Acta neurologica Scandinavica.
[9] P. Black,et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] T. Mikkelsen,et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.
[12] W. Vandertop,et al. Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. , 2008, Surgical neurology.
[13] M. Shigemori,et al. Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. , 2007, Surgical neurology.
[14] H. Mehdorn,et al. Glioblastoma—the consequences of advanced patient age on treatment and survival , 2006, Neurosurgical Review.
[15] Timothy C Ryken,et al. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.
[16] Wei Huang,et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. , 2003, Journal of neurosurgery.
[17] Reto Meuli,et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[19] S. Croul,et al. Treatment of malignant astrocytomas with repetitive resections: a longitudinal study. , 2001, The Israel Medical Association journal : IMAJ.
[20] M Brada,et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] Faith Davis,et al. Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.
[22] M. Prados,et al. Survival and functional status after resection of recurrent glioblastoma multiforme. , 1998, Neurosurgery.
[23] A. Arslantaş,et al. Management of glioblastoma multiforme: with special reference to recurrence , 1997, Clinical Neurology and Neurosurgery.
[24] M. Berger,et al. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. , 1994, Neurosurgery.
[25] J. Schwade,et al. Retreatment of Intracranial Gliomas , 1994, Southern medical journal.
[26] M. Bernstein,et al. The value of reoperation for recurrent glioblastoma. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.
[27] K. Wallner,et al. Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] N. Vick,et al. Reoperation for malignant astrocytoma , 1989, Neurology.
[29] P. Gutin,et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. , 1987, Neurosurgery.
[30] M. Ammirati,et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. , 1987, Neurosurgery.
[31] M. Salcman,et al. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. , 1982, Neurosurgery.
[32] W. Markesbery,et al. Reoperation for glioblastoma. , 1981, Journal of neurosurgery.
[33] I. Yang. Impact of bevacizumab chemotherapy on craniotomy wound healing , 2012 .
[34] B. Tuğcu,et al. Efficacy of clinical prognostic factors on survival in patients with glioblastoma. , 2010, Turkish neurosurgery.
[35] D. Áfra,et al. Re-operations of supratentorial anaplastic astrocytomas , 2007, Acta Neurochirurgica.
[36] Susan M. Chang,et al. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. , 2004, Journal of neurosurgery.
[37] M. Pinsker,et al. Experiences with reoperation on recurrent glioblastoma multiforme , 2001, Zentralblatt fur Neurochirurgie.
[38] L. Deangelis,et al. Brain Tumors , 2019, Imaging Gliomas After Treatment.
[39] P. Malmström,et al. Reoperation for malignant astrocytomas: personal experience and a review of the literature. , 1993, British journal of neurosurgery.